Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1309

1.

Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer.

Eisermann K, Tandon S, Bazarov A, Brett A, Fraizer G, Piontkivska H.

BMC Genomics. 2008 Jul 16;9:337. doi: 10.1186/1471-2164-9-337.

2.

Integrating genomic data to predict transcription factor binding.

Holloway DT, Kon M, DeLisi C.

Genome Inform. 2005;16(1):83-94.

PMID:
16362910
3.

Identification of estrogen-responsive genes using a genome-wide analysis of promoter elements for transcription factor binding sites.

Kamalakaran S, Radhakrishnan SK, Beck WT.

J Biol Chem. 2005 Jun 3;280(22):21491-7. Epub 2005 Mar 24.

4.

Characterization of two functional NKX3.1 binding sites upstream of the PCAN1 gene that are involved in the positive regulation of PCAN1 gene transcription.

Liu W, Zhang P, Chen W, Yu C, Cui F, Kong F, Zhang J, Jiang A.

BMC Mol Biol. 2008 May 4;9:45. doi: 10.1186/1471-2199-9-45.

5.

Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.

Zaia A, Fraizer GC, Piantanelli L, Saunders GF.

Anticancer Res. 2001 Jan-Feb;21(1A):1-10.

PMID:
11299720
6.

Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells.

Ruiz M, Pettaway C, Song R, Stoeltzing O, Ellis L, Bar-Eli M.

Cancer Res. 2004 Jan 15;64(2):631-8.

7.

A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus.

Kaushal A, Myers SA, Dong Y, Lai J, Tan OL, Bui LT, Hunt ML, Digby MR, Samaratunga H, Gardiner RA, Clements JA, Hooper JD.

Prostate. 2008 Mar 1;68(4):381-99. doi: 10.1002/pros.20685.

PMID:
18196551
8.

Ornithine decarboxylase is a transcriptional target of tumor suppressor WT1.

Li RS, Law GL, Seifert RA, Romaniuk PJ, Morris DR.

Exp Cell Res. 1999 Feb 25;247(1):257-66.

PMID:
10047468
9.

RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.

Fowler M, Borazanci E, McGhee L, Pylant SW, Williams BJ, Glass J, Davis JN, Meyers S.

J Cell Biochem. 2006 Jan 1;97(1):1-17.

PMID:
16237704
10.

Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters.

Kininis M, Chen BS, Diehl AG, Isaacs GD, Zhang T, Siepel AC, Clark AG, Kraus WL.

Mol Cell Biol. 2007 Jul;27(14):5090-104. Epub 2007 May 21.

11.

EGR1 target genes in prostate carcinoma cells identified by microarray analysis.

Svaren J, Ehrig T, Abdulkadir SA, Ehrengruber MU, Watson MA, Milbrandt J.

J Biol Chem. 2000 Dec 8;275(49):38524-31.

12.
13.

The atypical GATA protein TRPS1 represses androgen-induced prostate-specific antigen expression in LNCaP prostate cancer cells.

van den Bemd GJ, Jhamai M, Brinkmann AO, Chang GT.

Biochem Biophys Res Commun. 2003 Dec 19;312(3):578-84.

PMID:
14680804
14.

Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.

Weng J, Ma W, Mitchell D, Zhang J, Liu M.

J Cell Biochem. 2005 Dec 1;96(5):1034-48.

PMID:
16149059
15.

GATA-1 transactivates the WT1 hematopoietic specific enhancer.

Wu Y, Fraizer GC, Saunders GF.

J Biol Chem. 1995 Mar 17;270(11):5944-9.

16.

Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate.

Kinoshita M, Nakagawa T, Shimizu A, Katsuoka Y.

Int J Urol. 2005 Apr;12(4):390-7.

17.

The PTEN tumor suppressor is a negative modulator of androgen receptor transcriptional activity.

Nan B, Snabboon T, Unni E, X-J Yuan, Whang YE, Marcelli M.

J Mol Endocrinol. 2003 Aug;31(1):169-83.

PMID:
12914534
18.

Functional properties of WT1.

Haber DA, Englert C, Maheswaran S.

Med Pediatr Oncol. 1996 Nov;27(5):453-5.

PMID:
8827073
19.

GREB1 is a novel androgen-regulated gene required for prostate cancer growth.

Rae JM, Johnson MD, Cordero KE, Scheys JO, Larios JM, Gottardis MM, Pienta KJ, Lippman ME.

Prostate. 2006 Jun 1;66(8):886-94.

PMID:
16496412
20.

Activation of the WT1 tumor suppressor gene promoter by Pea3.

Discenza MT, Vaz D, Hassell JA, Pelletier J.

FEBS Lett. 2004 Feb 27;560(1-3):183-91.

Supplemental Content

Support Center